Major Relief for Patients: Medicines & Devices Get Cheaper in Delhi!

Major Relief for Patients: Medicines & Devices Get Cheaper in Delhi!

Patients in Delhi and across India will soon experience lower healthcare costs. Consequently, the Delhi Drugs Control Department has directed pharmaceutical manufacturers and medical device marketers to revise their Maximum Retail Prices (MRPs) in alignment with new, reduced tax rates. This crucial compliance order, issued on September 17, paves the way for a significant price drop on September 22.

Understanding the New GST on Medicines and Devices

The 56th GST Council Meeting, held on September 3, 2025, ushered in a major rationalisation of healthcare tax slabs. Notably, the GST rate on most drugs and formulations has been slashed from 12% to 5%. In addition, thirty-three essential life-saving medicines, including some used for cancer and rare diseases, now enjoy a complete GST exemption. Furthermore, medical devices such as glucometers, diagnostic kits, and reagents will also become more affordable, as their tax rates have been significantly reduced from 12-18% to a uniform 5%.

This widespread reduction in GST on medicines and devices directly translates into lower out-of-pocket expenses for patients. For example, a medicine previously costing Rs 1,000 will now be available for approximately Rs 950. This represents a substantial saving for individuals managing chronic conditions or requiring critical treatments. The government aims to make healthcare more accessible and affordable for the common person.

Ensuring Compliance and Patient Benefit with New GST on Medicines

To implement these changes effectively, the Delhi Drugs Control Department has instructed companies to revise MRPs on product labels. This can be achieved through stamping, stickering, or overprinting, but strictly to reflect the new GST-linked price. Critically, other label details, including the original printed MRP, must remain unchanged.

Interestingly, the Centre has waived the mandatory requirement of recalling or re-stickering existing stocks of medicines and medical devices already in the market, provided companies ensure retailers adhere to the revised pricing. Manufacturers must, however, issue revised or supplementary price lists to dealers, retailers, state regulators, and consumers to guarantee compliance at the retail level. The department has clarified that such label revisions require a no-objection certificate from the state licensing authority under Rule 104A of the Drugs Rules, 1945. Officials emphasize that this directive aims to ensure the benefits of GST rationalisation directly reach patients, rather than being absorbed by intermediaries. For those involved in pharmaceutical practices, understanding these regulatory changes is crucial. Pursuing a Certification Course In Safe Prescribing can provide valuable insights into regulatory compliance and best practices in medication management.

Frequently Asked Questions

Q1: When will the new GST rates for medicines and medical devices take effect?

A: The new, reduced GST rates for medicines and medical devices will take effect from September 22, 2025.

Q2: How will the GST cuts impact the price of life-saving medicines?

A: Thirty-three essential life-saving medicines, including those for cancer and rare diseases, have been made completely GST-free. Most other drugs and formulations have seen their GST reduced from 12% to 5%.

Q3: Do manufacturers need to recall old stock for re-labeling after the GST reduction?

A: No, the Centre has waived the mandatory recall or re-stickering of existing stock if companies can guarantee that retailers adhere to the revised pricing. However, manufacturers must issue revised price lists.

References

1. Medicines, Devices to Get Cheaper as GST Cut Kicks In; Delhi Issues ComplianceOrder – ETHealthworld
2. GST Rate on Medicines and Other Pharmaceuticals – ClearTax
3. Impact of GST rate rationalization on the Pharma sector – EY
4. GST rate cut: Drugs regulator gives 3-month window for medical device units to revise MRP – Financial Express
5. Centre waives mandatory relabeling of drugs, medical devices after GST cut – Medical Buyer
6. Medicines, Devices to Get Cheaper as GST Cut Kicks In; Delhi Issues Compliance Order – The Economic Times
7. Medicine prices set to drop from September 22 with GST cut, RDCA confirms new billing rates – Pharmabiz.com
8. Recommendations of the 56th Meeting of the GST Council held at New Delhi, today – PIB
9. After GST Rate Cut, Govt Waives Mandatory Re-Labelling Of Medicines – Zee News
10. Medicines, medical devices to get cheaper from Sept 22 under new GST regime – The Economic Times

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.